Ablexis is a company that commercializes a transgenic mouse platform AlivaMab for human therapeutic antibody discovery. It offers synthetic, autonomously functioning heavy, kappa, and lambda immunoglobulin transgenes, combinations of human and mouse coding and non-coding elements, etc.